Covance Inc. Increases Its Phase I Clinical Capacity With Acquisition Of Gfi Research Center

Covance Inc. (NYSE: CVD) added to its Phase I capacity and further enhanced its reputation for clinical excellence with the purchase today of GFI Clinical Services from West Pharmaceutical Services, Inc. (NYSE: WST).